Richard Straube

4.0k total citations · 2 hit papers
40 papers, 2.6k citations indexed

About

Richard Straube is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Richard Straube has authored 40 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Richard Straube's work include Neonatal Respiratory Health Research (7 papers), Sepsis Diagnosis and Treatment (6 papers) and Respiratory Support and Mechanisms (5 papers). Richard Straube is often cited by papers focused on Neonatal Respiratory Health Research (7 papers), Sepsis Diagnosis and Treatment (6 papers) and Respiratory Support and Mechanisms (5 papers). Richard Straube collaborates with scholars based in United States, Germany and United Kingdom. Richard Straube's co-authors include R. Phillip Dellinger, Janice L. Zimmerman, Elizabeth Ziegler, Charles L. Sprung, Jerald Sadoff, Charles J. Fisher, Craig R. Smith, Garrett E. Foulke, Harvey J. Berger and Nelson N.H. Teng and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PEDIATRICS.

In The Last Decade

Richard Straube

39 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin

1991 1.1k citations Elizabeth Ziegler, Charles J. Fisher et al. New England Journal of Medicine profile →
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome

1998 491 citations R. Phillip Dellinger, Janice L. Zimmerman et al. Critical Care Medicine profile →

Peers

Countries citing papers authored by Richard Straube

Since Specialization

Citations

This map shows the geographic impact of Richard Straube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Straube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Straube more than expected).

Fields of papers citing papers by Richard Straube

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Straube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Straube. The network helps show where Richard Straube may publish in the future.

Co-authorship network of co-authors of Richard Straube

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Straube. A scholar is included among the top collaborators of Richard Straube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Straube. Richard Straube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Post COVID and Apheresis – Where are we Standing? 2022 ·Hormone and Metabolic Research ·Charlotte Steenblock, (unknown), Sergey Tselmin, Natalia Jarzebska, (unknown), Nicole Toepfner, Timo Siepmann, Jens Passauer, Christian Hugo, (unknown), Ulrich Julius, Mahmoud Barbir, (unknown), Milo A. Puhan, Richard Straube, Bernd Hohenstein, Stefan R. Bornstein, Roman N. Rodionov	10
2	Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? 2021 ·Molecular Psychiatry ·Stefan R. Bornstein, (unknown), (unknown), Roman N. Rodionov, Raul R. Gainetdinov, Sergey Tselmin, Waldemar Kanczkowski, Gregor Müller, Martin Achleitner, Jun Wang, Julio Licínio, Michael Bauer, Allan H. Young, Sandrine Thuret, Nicole Bechmann, Richard Straube	56
3	Extracorporeal apheresis therapy for Alzheimer disease—targeting lipids, stress, and inflammation 2019 ·Molecular Psychiatry ·Stefan R. Bornstein, (unknown), Peter Rosenthal, Sergey Tselmin, Ulrich Julius, Ulrike Schatz, Bernhard O. Boehm, Sandrine Thuret, Gerd Kempermann, Heinz Reichmann, George P. Chrousos, Julio Licínio, Ma‐Li Wong, Andrew V. Schally, Richard Straube	21
4	Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine 2018 ·Vaccine ·Jennifer Westfall, Jennifer L. Yates, Greta Van Slyke, Dylan Ehrbar, (unknown), Richard Straube, Oreola Donini, Nicholas J. Mantis	15
5	Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients 2017 ·Biotechnology Reports ·Mahesh Kudrimoti, (unknown), (unknown), Francis P. Worden, Sanford Katz, Douglas R. Adkins, Marcelo Bonomi, (unknown), Jenna Elder, Stephen T. Sonis, Richard Straube, Oreola Donini	16
6	A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy 2016 ·Journal of Biotechnology ·John R. North, Shunsuke Takenaka, Annett Rozek, Agnieszka Kielczewska, Steven M. Opal, Lisa A. Morici, B. Brett Finlay, (unknown), Richard Straube, Oreola Donini	22
7	Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study 2016 ·Journal of Biotechnology ·Mahesh Kudrimoti, (unknown), (unknown), Francis P. Worden, Sanford Katz, Douglas Adkins, Marcelo Bonomi, Jenna Elder, Stephen T. Sonis, Richard Straube, Oreola Donini	55
8	Rheopherese bei rezidivierendem Hörsturz 2010 ·HNO ·(unknown), Richard Straube, Andreas Heibges, Reinhard Klingel, (unknown)	10
9	Membrane differential filtration is safe and effective for the long-term treatment of Refsum syndrome––an update of treatment modalities and pathophysiological cognition 2003 ·Transfusion and Apheresis Science ·Richard Straube, (unknown), (unknown), (unknown), (unknown), Reinhard Klingel	13
10	Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide 2002 ·The Journal of Pediatrics ·Paul H. Lipkin, Dennis Davidson, Lynn Spivak, Richard Straube, (unknown), Chee Tao Chang	95
11	Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome 2000 ·Critical Care Medicine ·Janice L. Zimmerman, R. Phillip Dellinger, Richard Straube, James L. Levin	61
12	Safety of Withdrawing Inhaled Nitric Oxide Therapy in Persistent Pulmonary Hypertension of the Newborn 1999 ·PEDIATRICS ·Dennis Davidson, Elaine S. Barefield, John Kattwinkel, Golde Dudell, Michael C. Damask, Richard Straube, (unknown), Cheng‐Tao Chang, (unknown)	65
13	Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase ntrial. Inhaled nitric oxide in ards study group 1998 ·Respiratory Care ·R. Phillip Dellinger, Janice L. Zimmerman, Robert W. Taylor, Richard Straube, (unknown), (unknown)	49
14	Lipoprotein (a) Immunapheresis in the Treatment of Familial Lipoprotein (a) Hyperlipoproteinemia in a Patient with Coronary Heart Disease 1998 ·Therapeutic Apheresis ·Richard Straube, (unknown)	11
15	Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome breakdown → 1998 ·Critical Care Medicine ·R. Phillip Dellinger, Janice L. Zimmerman, Robert W. Taylor, Richard Straube, (unknown), Gerard J. Criner, Kenneth Davis, Thomas M. Hyers, Peter J. Papadakos	491
16	Influence of alterations in forgoing life-sustaining treatment practices on a clinical sepsis trial 1997 ·Critical Care Medicine ·Charles L. Sprung, Leonid A. Eidelman, Reuven Pizov, Charles J. Fisher, Elizabeth Ziegler, Jerald Sadoff, Richard Straube, Richard V. McCloskey	23
17	Acute response to inhaled Nitric Oxide (NO) in Acute Respiratory Distress Syndrome (ARDS) 1996 ·CHEST Journal ·Janice L. Zimmerman, Robert W. Taylor, (unknown), Thomas M. Hyers, Richard Straube	2
18	Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome 1993 ·The Journal of Pediatrics ·(unknown), Gregory L. Kearns, Sheldon L. Kaplan, Richard F. Jacobs, Anthony Killian, John S. Bradley, Michele Moss, Russell Van Dyke, William Rodriguez, Richard Straube	8
19	Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin breakdown → 1991 ·New England Journal of Medicine ·Elizabeth Ziegler, Charles J. Fisher, Charles L. Sprung, Richard Straube, Jerald Sadoff, Garrett E. Foulke, Cornelis H. Wortel, Mitchell P. Fink, R. Phillip Dellinger, Nelson N.H. Teng, (unknown), Harvey J. Berger, Genell L. Knatterud, (unknown), Craig R. Smith, (unknown)	1116
20	Adenovirus Type 7b in a Children's Hospital 1983 ·The Journal of Infectious Diseases ·Richard Straube, Maxwell Thompson, Russell B. Van Dyke, Göran Wadell, James D. Connor, D L Wingard, Stephen A. Spector	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact